DL
Dan Leonard UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
10x Genomics
TXG
$1.74B
| $13.96 | $13 |
7%
downside
| Neutral | 28 days ago |
|
2
Exact Sciences
EXAS
$10.2B
| $53.81 | $53 |
2%
downside
| Neutral | 29 days ago |
|
3
Certara
CERT
$1.69B
| $10.52 | $15 |
43%
upside
| Buy | 29 days ago |
|
4
Medpace
MEDP
$13.7B
| $486.98 | $305 |
37%
downside
| Sell | 1 month ago |
|
5
Thermo Fisher Scientific
TMO
$186B
| $492.60 | $500 |
2%
upside
| Neutral | 1 month ago |
|
6
Danaher
DHR
$143B
| $200.21 | $225 |
12%
upside
| Buy | 1 month ago |
|
7
IQVIA
IQV
$31.9B
| $187.68 | $225 |
20%
upside
| Buy | 1 month ago |
|
8
Mettler-Toledo International
MTD
$26.9B
| $1,305.71 | $1,350 |
3%
upside
| Buy | 3 months ago |
|
9
Bio-Techne
TECH
$8.46B
| $54.41 | $70 |
29%
upside
| Buy | 3 months ago |
|
10
Bruker
BRKR
$4.68B
| $30.83 | $45 |
46%
upside
| Neutral | 4 months ago |
|
11
Bio-Rad Laboratories Class A
BIO
$8B
| $295.43 | $310 |
5%
upside
| Buy | 4 months ago |
|
12
Guardant Health
GH
$7.5B
| $60.13 | $70 |
16%
upside
| Buy | 4 months ago |
|
13
Revvity
RVTY
$10.1B
| $86.64 | $115 |
33%
upside
| Buy | 4 months ago |
|
14
Ryman Hospitality Properties
RHP
$6.35B
| $100.78 | $99 |
2%
downside
| Overweight | 5 months ago |
|
15
Avantor
AVTR
$9.07B
| $13.31 | $25 |
88%
upside
| Neutral | 7 months ago |
|
16
Charles River Laboratories
CRL
$8.07B
| $163.99 | $185 |
13%
upside
| Neutral | 7 months ago |
|
17
CryoPort
CYRX
$518M
| $10.35 | $9 |
13%
downside
| Neutral | 10 months ago |
|
18
Fulgent Genetics
FLGT
$672M
| $21.95 | $35 |
59%
upside
| Neutral | 1 year ago |
|
19
Agilent Technologies
A
$36.5B
| $128.75 | $150 |
17%
upside
| Outperform | 2 years ago |
|
20
Illumina
ILMN
$15.7B
| $98.93 | $200 |
102%
upside
| Neutral | 2 years ago |
|
|
21
Certara
CERT
$1.69B
| $10.52 | $21 |
100%
upside
| Outperform | 2 years ago |
|
22
Maravai LifeSciences
MRVI
$363M
| $2.51 | $11 |
338%
upside
| Neutral | 2 years ago |
|
|
23
Bio-Rad Laboratories Class A
BIO
$8B
| $295.43 | $525 |
78%
upside
| Overweight | 2 years ago |
|
|
24
Bio-Rad Laboratories Class A
BIO
$8B
| $295.43 | $550 |
86%
upside
| Outperform | 2 years ago |
|
25
Natera
NTRA
$23.1B
| $168.02 | $70 |
58%
downside
| Outperform | 2 years ago |
|